background: This study aims to quantify the non-health-care costs of endometriosis in a sample of Belgian patients over a 30-month period.
Introduction
In an era of spiraling health-care costs and limited resources, public policy-makers and health-care payers are concerned not only about the morbidity associated with endometriosis but also about the economic burden that endometriosis imposes on society. For instance, a cost-of-illness analysis estimated that annual endometriosis costs in the USA in 2002 amounted to $22 billion (Simoens et al., 2007) . The economic burden is not limited to health-care costs, but also includes direct non-health-care costs (e.g. child care costs while in treatment, transportation to health-care provider) and indirect non-health-care costs (e.g. absence from work, reduced productivity while at work, time lost from education and reduced ability to carry out day-to-day activities).
A literature review found that 85% of cost-of-illness analyses examined only the health-care costs of endometriosis (Gao et al., 2006) . In other words, little is known about the non-health-care costs associated with endometriosis. Nevertheless, available estimates suggest that endometriosis may impose considerable non-health-care costs. For instance, estimates of the number of hours missed from work because of endometriosis ranged from 19.2 to 86.4 h per patient per year (Kunz et al., 1995; Mathias et al., 1996) . The productivity loss of 86.4 h translated into annual indirect costs of $1023 per patient. The lack of attention to measuring indirect costs is a major concern given that patients suffering from endometriosis tend to belong to the population of working age (Bain, 2006) . There is a need for more data on the productivity loss associated with endometriosis.
The aim of this study is to quantify the non-health-care costs associated with endometriosis in a sample of Belgian patients over a 30-month period. The findings provide insight into one component of the economic burden associated with endometriosis. Furthermore, the cost data can be fed into economic evaluations, so that decisionmakers can ascertain the cost-effectiveness of various approaches to diagnosing and treating endometriosis by examining their effectiveness in relation to their costs.
Materials and Methods
This study was carried out in University Hospitals Leuven, a 1900-bed university hospital where physicians and residents carry out more than 18 000 major procedures on inpatients per year.
A longitudinal study followed up patients over a period stretching from 6 months prior to surgical treatment for endometriosis to 24 months following treatment. All women who underwent surgery between 1 September 2006 and 30 September 2008 at the Leuven University Fertility Center and who had histologically proved endometriosis were prospectively asked to participate in this follow-up study. Endometriosis was staged based on hospital records using the retrospective American Fertility Society (r-AFS) score (American Society for Reproductive Medicine, 1997) . Only patients who gave their written, informed consent for participation in the study were followed up. The study was approved by the ethical committee of University Hospitals Leuven.
Self-reported patient questionnaires (copies of the questionnaires are available from the corresponding author on request) enquired about costs associated with endometriosis and patient demographic characteristics at five time points: at 6 months prior to surgical treatment and at 6, 12, 18 and 24 months following treatment. At these time points, patients were asked to fill in cost data relating to the preceding 6-month period.
The questionnaire measured the number of days of work absence related to endometriosis during the previous 6 months. This productivity loss was valued using the gross monthly income reported by the patient. Direct non-health-care costs are related to patient expenditure on support with household activities (e.g. cleaning, ironing, child care) during the previous 4 weeks. This covered support with household activities provided by professionals and provided by family, friends or neighbours. Cost questions were derived from a published questionnaire about the costs of renal transplantation (Cleemput et al., 2004) and were adapted to the case of endometriosis in collaboration with the health economist who had developed the renal transplantation questionnaire. Demographic characteristics included the highest level of education, occupation, gross monthly income and marital status.
A descriptive analysis linearly extrapolated costs per patient over 6-month periods. The Kolmogorov-Smirnov test was applied to check for normality of cost data. If data were not normally distributed, the association between costs and demographic characteristics was explored using the Mann-Whitney U-test. Costs were compared between time periods (i.e. 6 months prior to treatment; 6, 12, 18 and 24 months following treatment) using the Wilcoxon-matched pairs test. All data were processed and analysed using the Statistical Package for the Social Sciences for Windows 17.0. Statistical significance was set at P , 0.05. Data are presented as mean + SD.
Results
At the time of analysis, a total of 394 patients were eligible for inclusion in the study. Of those patients, 180 were willing to participate in this cost study and provided informed consent (response rate of 46%). The demographic characteristics of the patient sample are displayed in Table I . The mean age of patients was 31 years (+ 4.9 years). Around 50% of patients suffered from severe endometriosis (r-AFS Stage IV). The majority of patients (91%) had a relationship. With respect to the highest educational level, 30% of patients had attained upper secondary level, 40% had post-secondary level (except for university) and 20% had university level. cent of patients were white collar workers. The gross monthly income was relatively evenly distributed across answer categories, although 25% of patients (n ¼ 46) were not able or not willing to report their income. A number of patients dropped out of the study owing to disappearance of endometriosis symptoms after surgery and/or pregnancy (both aims of the surgery), lack of time or lack of interest. As a result, the number of patients decreased from 180 patients at 6 month prior to surgical treatment to 142 patients at 6 months, 116 patients at 12 months, 67 patients at 18 months and 49 patients at 24 months following treatment (Table II) . Table II shows non-health-care costs per patient during successive 6-month periods. These data show that the highest productivity loss was incurred during the 6 months prior to surgical treatment (E1514 + 2576) and during the 6 months following treatment (E2496 + 4144). Mean costs dropped substantially to E117-E223 during the following 6-month periods. This trend was confirmed when the sample was limited to patients who completed questionnaires during the five time periods: costs of productivity loss amounted to E1516 + 165 during the 6 months prior to treatment and to E3500 + 4950 during the 6 months following treatment, after which they dropped to E933 -E1400 during the following 6-month periods. Costs of productivity loss were higher during the 6 months following treatment as compared with the 6 months prior to surgical treatment (P ¼ 0.001) and as compared with 12 months following treatment (P ¼ 0.013). No significant differences were found comparing the 6 months prior to surgery with the 18 months (P ¼ 0.715) and 24 months (P ¼ 0.180) following treatment.
The costs of additional support with household activities peaked during the 6 months prior to surgical treatment (E982 + 908) and during the 6 months following surgical treatment (E981 + 1085), after which they dropped to E513 -E675 during the following 6-month periods (see Table II ). This trend was also observed when the sample was limited to patients who completed questionnaires during the five time periods (n ¼ 49): the highest costs of additional support with household activities were incurred during the 6 months prior to treatment (E104 + 577) and during the 6 months following treatment (E93 + 485), after which they dropped to E25-E39 during the following 6-month periods. No significant differences were observed when comparing costs between time periods for this subgroup of patients (P . 0.05).
Total non-health-care costs over the 30-month period were higher for patients suffering from severe endometriosis (r-AFS Stage IV) (E4943) than for patients suffering from minimal-to-moderate endometriosis (r-AFS Stages I -III) (E4510) (P ¼ 0.048). No statistically significant association was found between non-health-care costs and the highest level of education.
Discussion
This longitudinal analysis has demonstrated that endometriosis is associated with substantial non-health-care costs in the form of productivity loss and additional support with household activities. Owing to limitations in design and scope, our study has likely underestimated the non-health-care costs of endometriosis given that the costs of reduced productivity while at work and the costs of transportation to the health-care provider were not included. Also, our study did not consider the non-health-care costs that endometriosis imposes on the partner, family or friends of patients (e.g. a husband who takes leave from work to care for a patient).
To the best of the authors' knowledge, this is the first study that computes non-health-care costs in patients with endometriosis over an extended time horizon of 30 months. This study has shown that the highest non-health-care costs are incurred during the 6 months prior to and following surgical treatment. In addition to these non-health-care costs, attention needs to be paid to the health-care costs incurred during this time period. Indeed, previous research has demonstrated that surgery accounts for most of the health-care costs of endometriosis and that the well-documented long diagnostic delay between initial symptoms and diagnosis of endometriosis generates health-care costs (Kennedy et al., 2005) .
Our study has found that non-health-care costs were significantly higher for patients suffering from severe endometriosis (r-AFS Stage IV) than for patients suffering from minimal-to-moderate Non-health-care costs of endometriosis endometriosis (r-AFS Stages I-III). Independently from the r-AFS stage, there may be an association between pain felt by women with endometriosis and non-health-care costs. Indeed, research has demonstrated that women with endometriosis frequently report pain severe enough to interfere with work productivity, thereby generating non-health-care costs (Gao et al., 2006) . Ideally, the true cost of a disease is measured by the additional burden associated with that disease on society. Therefore, the questionnaires emphasized that patients should report non-health-care costs associated with endometriosis only. Alternatively, a casecontrol study design could have been used. As a result of practical and resource constraints, our study did not include a control population of women without endometriosis, as is also the case in most other cost-of-illness analyses.
Our cost estimates need to be interpreted with caution. First, the costs of additional support with household activities are likely to be underestimated given that family, friends or neighbours who carry out these activities do not always ask for a financial compensation. Second, cost estimates were subject to large SDs as a result of, for example, differences in the number of days of work absence or differences in gross monthly income between patients. Third, our estimates were based on patient self-reported data. A patient questionnaire can be an efficient method to study a sample but reliability of questionnaire data may be hindered by patients' ability to recall resource use and expenditure related to a disease. Also, the large variability observed in cost estimates may reflect the fact that patients are not used to answering questions about productivity loss and additional support with household activities. Fourth, the study suffered from a low response rate (46%) and our sample may not be representative, as patients were enrolled in a tertiary care centre which typically treats more complex and referred cases of endometriosis. However, the proportion of women with minimal -mild (29%) and moderate-severe (71%) endometriosis in our study was comparable to the proportion of minimal-mild (37%) and moderatesevere (63%) in the whole Icelandic population over a 20-year period (Gylfason et al., 2010) . Given the variability in cost estimates reported by all patients and by the sub-sample of patients who completed the questionnaires during the five time periods, the reader should note that this subsample of patients may be highly motivated to answer the questions, although they had similar demographic characteristics as the full sample. Finally, our cost estimates were specific to the studied Belgian sample and may not be generalisable to other settings or countries.
Future research needs to confirm our estimates of the non-health-care costs associated with endometriosis in other settings or countries. In addition to productivity loss and additional support with household activities, studies need to quantify the costs of days lost to education, costs of reduced productivity at work and the costs of reduced ability to carry out usual daily activities. Also, there is a need to examine the relationship between patient characteristics and non-health-care costs. In particular, research is required that computes non-health-care costs for different degrees of endometriosis severity as the relationship between endometriosis severity and costs is still unclear.
Cost estimates provided by this analysis can be used to determine priorities for and to inform future research on endometriosis. To reduce the economic burden associated with endometriosis, attention needs to be focused on decreasing the productivity loss arising from endometriosis. There is a need for more timely diagnosis of endometriosis as any diagnostic delay not only generates health-care costs but also raises costs of productivity loss. For instance, a recent study has shown that the history of a woman's periods during adolescence is a predictor of the development of endometriosis and that women with endometriosis had more absenteeism from school during menstruation (Chapron et al., 2011) . Furthermore, women with endometriosis frequently report an impairment of quality of life and clinical symptoms severe enough to interfere with work productivity, and social and daily activities (Gao et al., 2006) . Therefore, the implementation of new interventions to prevent, diagnose and treat endometriosis may influence costs of productivity loss.
Future studies exploring the impact of new interventions to prevent, diagnose and treat endometriosis need to consider non-health-care costs in addition to health-care costs, and balance those costs against the effectiveness of treatment techniques. The inclusion of such non-health-care costs is expected to result in more favourable cost-effectiveness ratios of interventions, if those interventions improve clinical symptoms and thereby reduce non-health-care costs.
